Hypercapnic COPD Exacerbation with Drowsiness and Limited Respiratory Support
A 67-year-old man with COPD (FEV1 42% predicted) and two previous admissions for exacerbations presents with 2 days of increased breathlessness and purulent sputum. He is drowsy but rousable and can answer simple questions. He has been using his salbutamol inhaler frequently and has not taken prednisolone. On arrival, BP is 138/80 mmHg, pulse 102/min, respiratory rate 28/min, and SpO2 88% on a 28% Venturi mask. Chest examination shows widespread wheeze and reduced air entry at both bases, with no focal crackles. Arterial blood gas on 28% oxygen: pH 7.28, PaCO2 72 mmHg, PaO2 55 mmHg, bicarbonate 32 mmol/L. Chest radiograph shows hyperinflation but no consolidation or pneumothorax. He lives alone and has a documented ceiling of care of ward-based treatment, not invasive ventilation. The ward has one non-invasive ventilation machine available.
1. What is the immediate oxygen and ventilatory management, and how would you decide between NIV and intubation?
Read the worked answer
This is an acute hypercapnic exacerbation of COPD with respiratory acidosis. He is already at risk from uncontrolled oxygen, so target SpO2 88–92% using a controlled oxygen device and recheck blood gases. Start nebulised bronchodilators, systemic corticosteroids, and antibiotics for a purulent exacerbation. He is drowsy but rousable and can protect his airway, so drowsiness alone is not an absolute contraindication to NIV. He has a ceiling of care excluding invasive ventilation, so NIV is the appropriate ceiling if he is cooperative and can be monitored. Start NIV with close observation and repeat blood gas at 1–2 hours. If pH improves and PaCO2 falls, continue. If he becomes exhausted, cannot protect his airway, develops vomiting, or has worsening acidosis despite optimal NIV, then escalate for senior review and palliative planning, because invasive ventilation is not agreed. Do not simply give more oxygen; that may worsen hypercapnia.
2. What ward-level monitoring and escalation plan would you put in place, given limited NIV availability?
Read the worked answer
Because there is only one NIV machine, allocate it to the patient most likely to benefit and who has a realistic ceiling of care. For this man, start NIV and monitor conscious level, respiratory rate, SpO2, blood gases, and tolerance. Repeat the blood gas within 1–2 hours and after any change. Check electrolytes and glucose, and watch for drowsiness that could be due to worsening CO2 retention rather than fatigue. Escalate to a senior respiratory or critical-care clinician if he is not improving, if he becomes difficult to rouse, or if he cannot manage NIV. Because his ceiling is ward-based treatment, the escalation plan should be explicit: optimise NIV and medical therapy, but do not proceed to intubation. Discuss with the family and document the plan. If another patient needs the machine urgently, the decision must be based on likelihood of benefit and agreed ceilings, not simply on arrival order.
3. What would make you suspect that this is not a simple COPD exacerbation?
Read the worked answer
Consider alternative or additional diagnoses if there is fever with focal signs, purulent sputum with systemic toxicity, or radiographic consolidation, which would suggest pneumonia. Sudden pleuritic pain, unilateral leg swelling, or unexplained hypoxia should prompt evaluation for pulmonary embolism. If he has been on diuretics or has a history of heart failure, consider pulmonary oedema, although his chest is wheezy rather than crackly. Check whether he has taken sedatives or opioids, which can cause hypercapnia and drowsiness. Consider pneumothorax if there is sudden deterioration with unilateral reduced air entry, and check the chest radiograph carefully. A drug history is important because benzodiazepines, opioids, and excessive oxygen can all worsen hypercapnia. The key judgement is to treat the COPD exacerbation but to keep looking for a reversible cause of failure to improve, especially if NIV does not produce the expected fall in PaCO2.